Continued aspirin treatment safe with partial nephrectomy

April 25, 2016

(HealthDay)—Continuing aspirin for chronic antiplatelet therapy is safe in patients undergoing laparoscopic partial nephrectomy, according to a study published in the April issue of The Journal of Urology.

David A. Leavitt, M.D., from the Hofstra North Shore LIJ School of Medicine in New Hyde Park, N.Y., and colleagues evaluated perioperative outcomes among 430 consecutive patients undergoing laparoscopic partial nephrectomy (January 2012 to October 2014). Patients were stratified between whether they continued or stopped treatment preoperatively.

The researchers found that among 101 patients (23.4 percent) on chronic aspirin , 17 continued antiplatelet treatment (16.8 percent). One patient in the aspirin group developed bleeding postoperatively and required angioembolization. In the off-aspirin cohort, one was observed. There were no significant differences in the incidence of major postoperative complications, intraoperative blood loss, transfusion rate, length of hospital stay, or rehospitalization rate. Continued aspirin use was tied to significantly increased operative time (181 versus 136 minutes; P = 0.01).

"Laparoscopic partial nephrectomy is safe and effective in on chronic antiplatelet therapy who require perioperative aspirin for cardioprotection," the authors write.

Explore further: OK to continue aspirin therapy up to pancreatic surgery

More information: Abstract
Full Text

Related Stories

OK to continue aspirin therapy up to pancreatic surgery

August 1, 2013
(HealthDay)—Patients on aspirin therapy do not have higher rates of perioperative bleeding, transfusion, or major procedure-related complications following elective pancreatic surgery, according to research published online ...

Long duration dual antiplatelet treatment increases bleeding

October 1, 2015
(HealthDay)—Routine use of dual antiplatelet therapy (DAPT) beyond six months after second generation drug-eluting stent (DES) implantation yields mixed clinical results, according to a review published in the October issue ...

Research reveals aspirin is safe for heart surgery patients

February 25, 2016
A worldwide study led by Monash University clinician-researchers shows that patients who take aspirin before heart surgery are at no greater risk of bleeding or complications. 

Surveillance beats radical nephrectomy for small masses

September 25, 2015
(HealthDay)—Patients with small renal masses who have a radical nephrectomy are significantly more likely to experience up staging to a more advanced chronic kidney disease stage based on glomerular filtration rate ranges, ...

Review: Short vs. long duration dual antiplatelet Tx after stent

June 5, 2015
(HealthDay)—Dual antiplatelet therapy (DAPT) continued beyond six months after drug-eluting stent implantation is associated with reduced stent thrombosis and myocardial infarction but also increased bleeding and all-cause ...

Prehospital antiplatelets improve graft intervention outcomes

January 28, 2013
(HealthDay)—Prehospital use of antiplatelet therapy, either aspirin/clopidogrel or dual antiplatelet therapy (DAPT), is associated with a lower incidence of major adverse cardiac events after saphenous vein graft (SVG) ...

Recommended for you

Zika virus stifles pregnant women's weakened immune system to harm baby, study finds

August 21, 2017
The Zika virus, linked to congenital birth defects and miscarriages, suppresses a pregnant woman's immune system, enabling the virus to spread and increasing the chances an unborn baby will be harmed, a Keck School of Medicine ...

Fatty liver can cause damage to other organs via crosstalk

August 21, 2017
Nonalcoholic fatty liver disease is increasingly common. Approximately every third adult in industrialized countries has a morbidly fatty liver. This not only increases the risk of chronic liver diseases such as liver cirrhosis ...

Faulty gene linked to obesity in adults

August 18, 2017
Groundbreaking new research linking obesity and metabolic dysfunction to a problem in the energy generators in cells has been published by researchers from the Harry Perkins Institute of Medical Research and The University ...

Two lung diseases killed 3.6 million in 2015: study

August 17, 2017
The two most common chronic lung diseases claimed 3.6 million lives worldwide in 2015, according to a tally published Thursday in The Lancet Respiratory Medicine.

New test differentiates between Lyme disease, similar illness

August 16, 2017
Lyme disease is the most commonly reported vector-borne illness in the United States. But it can be confused with similar conditions, including Southern Tick-Associated Rash Illness. A team of researchers led by Colorado ...

Addressing superbug resistance with phage therapy

August 16, 2017
International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.